Putative roles of circulating resistin in patients with asthma, COPD and cigarette smokers

Disease Markers

Volumn 31, Issue 1, 2011, Pages 1-7

  Al Mutairi, Sana S ^a   Mojiminiyi, Olusegun A ^a   Shihab Eldeen, Aida ^a   Al Rammah, Tahani ^a   Abdella, Nabila ^a  

^a KUWAIT UNIVERSITY   (Kuwait)

Author keywords

Asthma; chronic obstructive pulmonary diseases; insulin resistance; resistin; smokers

Indexed keywords

COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C4; GLUCOSE; INSULIN; RESISTIN;

ADULT; AGED; ARTICLE; ASTHMA; CHRONIC OBSTRUCTIVE LUNG DISEASE; CIGARETTE SMOKING; CONTROLLED STUDY; DISEASE EXACERBATION; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; GLUCOSE BLOOD LEVEL; HOMEOSTASIS; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LIPID ANALYSIS; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; PNEUMONIA; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION;

EID: 80052050077     PISSN: 02780240     EISSN: 18758630     Source Type: Journal    
DOI: 10.3233/DMA-2011-0793     Document Type: Article

References (33)

1. C.M. Steppan, S.T. Bailey, S.T. Bhat et al., The hormone resistin links obesity to diabetes, Nature 409 (2001), 307-312. (Pubitemid 32151228)
2. L. Patel, A.C. Buckels, I.J. Kinghorn et al., Resistin is expressed in human macrophages and directly regulated by PPAR activators, Biochem Biophys Res Commun 300 (2003), 472-476. (Pubitemid 38375833)
3. H.-C. Fehmann and J. Heyn, Plasma resistin levels in patients with type 1 and type 2 diabetesmellitus and in healthy controls, Horm Metab Res 34 (2002), 671-673. (Pubitemid 36398705)
4. J.H. Lee, J.L. Chan, N. Yiannakouris et al., Circulating resistin levels are not associated with obesity or insulin resistance in humans and are not regulated by fasting or leptin administration: cross-sectional and interventional studies in normal, insulin-resistant, and diabetic subjects, J Clin Endocrinol Metab 88 (2003), 4848-4856. (Pubitemid 37357535)
5. P.G. McTernan, F.M. Fisher, F.M. Valsamakis et al., Resistin and type 2 diabetes: regulation of resistin expression by insulin and rosiglitazone and the effects of recombinant resistin on lipid and glucose metabolism in human differentiated adipocytes, J Clin Endocrinol Metab 88 (2003), 6098-6106. (Pubitemid 38033098)
6. O.A. Mojiminiyi and N.A. Abdella, Association of resistin with inflammation and insulin resistance in patients with type 2 diabetes mellitus, Scandinavian J of Clinical and Laboratory Investigation 67 (2007), 215-225. (Pubitemid 46410615)
7. M. Lehrk, M.P. Reilly, S.C. Millington, N. Iqbal, D.J. Rader and M.A. Lazar, An inflammatory cascade leading to hyperreisitinemia in humans, Plos Medicine/ Public Library of Science 1 (2004), e45.
8. P.G.McTernan, C.M. Kusminski and S. Kumar, Resistin, Current Opinion in Lipidology 17 (2006), 170-175.
9. S.S. Pang and Y.Y. Le, Role of resistin in inflammation and inflammation-related diseases, Cellular & Molecular Immunology 3 (2006), 29-34.
10. J. Larochelle, J. Freiler, J. Dice and J. Hagan, Plasma resistin levels in asthmatics as marker of disease state, J Asthma 44 (2007), 509-513. (Pubitemid 47450652)
11. A. Mishra, M. Wang, J. Scholtman et al., Resistin-like molecule -beta is an allergen -induced cytokine with inflammatory and remodeling activity in the murine lung, Am J Physio Lung Cell Mol Physiol 293 (2007), L305-L313. (Pubitemid 47205011)
12. G.K. Shetty, P.A. Economides, E.S. Horton, C.S. Mantzoros and A. Veves, Circulating adiponectin and resistin levels in relation to metabolic factors , in flammatory markers, and vascular reactivity in diabetics patients and subjects at risk of diabetes, Diabetes Care 27 (2004), 2450-2457. (Pubitemid 39281400)
13. O.A. Mojiminiyi, F. Al Mulla, N.A. Abdella, Which obesity index best explains the link between adipokines, coronary heart disease risk and metabolic abnormalities in type 2 diabetes mellitus? Med Princ Pract 18 (2009), 123-129.
14. H. Raff andE.D.Bruder, Adiponectin and resistin in the neonatal rat: effects of dexamethosone and hypoxia, Endocrine 29 (2006), 341-344. (Pubitemid 44097376)
15. P. Trayhurn and I.S. Wood, Adipokines: inflammation and the pleiotropic role of white adipose tissue, British Journal of Nutrition 92 (2004), 347-355. (Pubitemid 40277057)
16. F.I.E. Najam, A.S.M. Giasuddin and A.H. Shembesh, Complement components (C3, C4) in childhood asthma, Indian J Pediatr 72 (2005), 745-749.
17. M.M. Marc, P. Korosec, M. Kosnik et al., Complement factors C3a, C4a, and C5a in chronic obstructive pulmonary disease and asthma, Am J Respire Cell Mol Boil 31 (2004), 216-219. (Pubitemid 39095451)
18. E.N. Kosmas, D. Zorpidodou, V. Vassilareas, T. Roussou and S. Michaelides, Decreased C4 complement component serum levels correlate with the degree of emphysema in patients with chronic bronchitis, Chest 112 (1997), 341-347. (Pubitemid 27349422)
19. National Asthma Education and Prevention Program: Expert PanelReport III: Guidelines for the diagnosis andmanagement of asthma. Bethesda, MD. National Heart, Lung, and Blood Institute, 2007. (NIH publication no. 08-4051). Available from www.nhlbi.nih.gov/guidelines/asthma/asthgdln.htm .
20. R.A. Pauwels, A.S. Buist, P.M. Calverley, R.C. Jenkins and S.S. Hurd, On the behalf of the Gold Scientific Committee. Global strategies for the diagnosis, management and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for chronic obstructive lung disease (GOLD) Workshop Summary, Am J Resp Crit Care Med 163 (2001), 1256-1276.
21. World Health Organisation. Measuring obesity: classification and distribution of anthropometric data. Copenhagen: WHO, 1989. (Nutr UD, EUR/ICP/NUT 125).
22. Standardization of Spirometry, 1994 Update. American Thoracic Society, Am J Resp Crit Care Med 152 (1995), 1107-1136.
23. W.T. Friedewald, R.T. Levy and D.S. Fredrickson, Estimation of the concentration of low density lipoprotein cholesterol in plasma without use of the ultracentrifuge, Clin Chem 18 (1972), 449-502.
24. Homeostasis model assessment (HOMA) formula using a calculator downloaded from . html?maindoc=/publications/: date accessed May 2008.
25. G. Raes, L. Brys, B.K. Dahal et al., Macrophage galactosetype C-type lectins as novel markers for alternatively activate ed macrophages elicited by parasitic infections and allergic airway inflammation, J Leukoc Biol 77 (2005), 321-327. (Pubitemid 40289561)
26. L. Patel, A.C. Buckels, I.J. Kinghorn et al., Resistin is expressed in human macrophages and directly regulated by PPAR gamma activators, Biochem Biophys Res Commun 300 (2003), 472-476. (Pubitemid 38375833)
27. A. Mishra, M. Wang, J. Schlotman et al., Resistin-like molecule-beta is an allergen-induced cytokine with inflammatory and remodeling activity in the murine lung, American Journal of Physiology - Lung Cellular & Molecular Physiology 293 (2007), L305-L313. (Pubitemid 47205011)
28. R.P. Schleimer, Innate Immune Responses and Chronic Obstructive PulmonaryDisease, "Terminator" or "Terminator 2"? The Proceedings of the American Thoracic Society 2 (2005), 342-346. (Pubitemid 41699694)
29. B. Braun, P.B. Rock, S. Zamudio, Wolfel et al., Women at altitude: short-term exposure to hypoxia and/or α1-adrenergic blockade reduces insulin sensitivity, J Appl Physiol 91 (2001), 623-631. (Pubitemid 32681090)
30. J.J. Larsen, J.M. Hansen, N.V. Olsen, H. Galbo and F. Dela, The effect of altitude hypoxia on glucose homeostasis in men, J Physiol 504 (1997), 241-249. (Pubitemid 27464289)
31. K.M. Oltmanns, H. Gehring, H. Rudolf et al., Hypoxia causes glucose intolerance in humans, Am J Respir Crit Care Med 169 (2004), 1231-1237. (Pubitemid 38680401)
32. N.R. Prabhakar and G.K. Kumar, Oxidative stress in the systemic and cellular responses to intermittent hypoxia, Biol Chem 385 (2004), 217-221. (Pubitemid 38679066)
33. G.K. Reaven and P.S. Tsao, Insulin resistance and compensatory hyperinsulinemia: the key player between cigarette smoking and cardiovascular disease? Journal of the American College of Cardiology 41 (2003), 1044-1047. (Pubitemid 36315551)